Efthymios Deliargyris

Technik-/Wissenschafts-/F&E-Leiter bei CYTOSORBENTS CORPORATION

Vermögen: 368 490 $ am 31.05.2024

55 Jahre

Health Technology

Consumer Services

Health Services

Aktive Positionen von Efthymios Deliargyris

Unternehmen	Position	Beginn	Ende
CYTOSORBENTS CORPORATION	Technik-/Wissenschafts-/F&E-Leiter	01.05.2020	-

Unternehmen	Position	Beginn	Ende
PLX PHARMA WINDDOWN CORP.	Technik-/Wissenschafts-/F&E-Leiter	01.08.2018	30.04.2020
ATHENS MEDICAL C.S.A.	Corporate Officer/Principal	01.01.2004	01.01.2010
Wake Forest University	Corporate Officer/Principal	01.01.2001	01.01.2004

National & Kapodistrian University of Athens

Doctorate Degree

International

Vereinigte Staaten	4
Griechenland	3

Operativ

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	2
Doctorate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
ATHENS MEDICAL C.S.A.	Health Services
CYTOSORBENTS CORPORATION	Health Technology

Private Unternehmen	1
PLx Pharma, Inc. PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of a technology platform for approved drugs. It offers the PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Dover, DE.	Health Technology

Private Unternehmen

Health Technology